A GING   I NTERVENTION
F OUNDATION

		L. Stephen Coles, MD, PhD -- Chief Science Officer      Steve Coles is considered by many to be the most knowledgeable person in aging intervention research.  Each month he presents the results of his extensive research at the meeting of the Los Angeles Gerontology Research Group. Co-Founder and Director of the Los Angeles Gerontology Research Group Visiting Scholar, Dept. of Computer Science, UCLA School of Engineering Former VP for Medical Education, The Kronos Group Member of the MaxLife Foundation Scientific Advisory Board Member of the Organizing Committee, Director and Treasurer of the Supercentenarian Research Foundation Author of over 115 scientific papers and holds two patents
		John C. Guerin   Founder Centenarian Species and Rockfish Projuect -- Emerging Area of Aging Research: Long-lived Animals with "Negligible Senescence" at www.AgelessAnimals.org Featured in a chapter of Mavericks of Medicine: Exploring the Future of Medicine with Andrew Weil, Jack Kevorkian, Bernie Siegel, Ray Kurzweil, and Others Meetings and organizations John has made presentations to include: International Association of Biomedical Gerontology 2003, AGE Conference (American Aging Association) 2001, American Aging Association 2000, Symposium on Organisms with Slow Aging 2000, and the Los Angeles Gerontology Research Group 1999 Member of the Editorial Advisory Board for the Handbook of Animal Models for Aging Academic Press/Elsevier Management Professional certification, issued by Project Management Institute Experience as senior accountant and business analyst. Led multi-department financial project teams. Projects included Pharmacy Billing, Comparable Sales and Wage reporting, Mail Routing and Warehouse Accruals
		John Furber – Mr. Furber is an entrepreneur and scientist who has been studying the biology of aging and regeneration for more than 20 years. He was a principal in starting five companies during the 1980s and 90s. Currently, he is running a biotechnology company, Legendary Pharmaceuticals, which is engaged in the discovery of pharmaceutical drugs and gene therapies able to repair and reverse accumulating molecular damage to subcellular mitochondria, lysosomes, nuclei, and extracellular proteins in order to prevent and treat serious, late-onset diseases commonly associated with aging.
		Michael Rose, PhD -- Dr. Rose has made significant contributions to the field of aging research. He is a professor in the Department of Ecology and Evolutionary, UC Irvine in Irvine CA USA. His main area of work has been the evolution of aging.
		Aubrey de Grey, PhD – Dr. de Grey works to identify and promote specific technological approaches to the reversal of the aspects of aging centered around the detailed plan called Strategies for Engineered Negligible Senescence (SENS).

If you are interested in supporting the foundation or
would like more information, click here to contact us